MMP9 and neoplasm: The study of the immunodetection of metalloproteases in PC-3 tumours revealed that the combined treatment caused a decrease in MMP-2 and MMP-9; in the latter case, this was similar, although somewhat weaker, to that obtained after treatment with MIA-690.